Sarcopenia Screening For Mortality In Oncology Patients Overview This study evaluated the effectiveness of a sarcopenia screening test in predicting mortality among cancer inpatients. Conducted over five months, 82 patients admitted to an oncology ward in southern Taiwan were assessed and followed for three years. Each participant underwent a comprehensive
Tag: Sarcopenia
Sarcopenia And Chronic Kidney Disease
Sarcopenia And Chronic Kidney Disease Overview Sarcopenia and frailty are common conditions among people with chronic kidney disease (CKD), which may further enhance their risk of developing adverse health complications. Only a few studies have demonstrated the association between sarcopenia, frailty and chronic kidney disease in patients who are not on dialysis.
Osteopenia predicts outcomes in pancreatic cancer
Osteopenia predicts outcomes in pancreatic cancer Study Background Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer deaths in the United States and is projected to become the second by 2030. The unfavorable prognosis of PDAC can be attributed to late diagnosis, poor metabolic status, and the resistance of cancer
skeletal muscle mass and cancer patient quality of life: a meta-analysis
skeletal muscle mass and cancer patient quality of life: a meta-analysis Loss of skeletal muscle mass (sarcopenia), is a widely prevalent problem among cancer patients with incidence ranging from 11 to 74%. Low skeletal muscle mass at baseline is predictive of poor cancer outcomes such as decreased overall survival, increased risk
